loader image
January 2023 Banner
MicrosoftTeams-image (5)
MicrosoftTeams-image (4)
COVID19 UPDATES
Slide
Slide
Slide 1
IEC
previous arrow
next arrow

Featured Activity

Featured Activity || FDA joins PPhA National Convention

On April 11 to 13 2024, the Philippine Pharmacists Association Inc. (PPhA) held its National Convention at the Iloilo Convention...
Read More
Featured Activity || FDA joins PPhA National Convention

Featured Activity || FDA BBMSME Training in Calamba City

The Food and Drug Administration (FDA) Regional Field Office IV-A conducted a two-day Seminar on FDA Regulatory Processes for forty...
Read More
Featured Activity || FDA BBMSME Training in Calamba City

Featured Activity || FDA MEETS WITH OSAPIEA

On 22 March 2024, the Food and Drug Administration (FDA) led by Director General Dr. Samuel A. Zacate met with...
Read More
Featured Activity || FDA MEETS WITH OSAPIEA

Featured Activity || DG Zacate Graced the 1st General Membership Meeting of PCPI

Director General Dr. Samuel A. Zacate of the Food and Drug Administration (FDA) graced the 1st General Membership Meeting (GMM)...
Read More
Featured Activity || DG Zacate Graced the 1st General Membership Meeting of PCPI

Featured Activity || Cascading of FDA-Related Laws, Rules, and Regulations

In a two-day Cascading of FDA-related laws, rules and regulations initiated by the Policy and Planning Service (PPS), respective lawyers...
Read More
Featured Activity || Cascading of FDA-Related Laws, Rules, and Regulations

Featured Activity || FDA Hosted the NALECC-SCOC 119th Regular Meeting

On March 20, 2024, the Food and Drug Administration Philippines hosted the 119th Regular Coordination Meeting of the National Law...
Read More
Featured Activity || FDA Hosted the NALECC-SCOC 119th Regular Meeting

Featured Activity || FDA DG Zacate Met with DA Secretary Laurel Jr.

Following President Ferdinand “Bongbong” R. Marcos Jr.'s directive during the Private Sector Advisory Council (PSAC) Health Sector Group Meeting ng...
Read More
Featured Activity || FDA DG Zacate Met with DA Secretary Laurel Jr.

Featured Activity || FDA and PEZA Introduces Pharmaceutical-Medical device (Pharma-Dev Zones) Ecozones to Accelerate Medical Manufacturing

Manila, Philippines - March 14, 2024 - The Philippine Economic Zone Authority (PEZA) is proud to unveil Pharmaceutical and Medical...
Read More
Featured Activity || FDA and PEZA Introduces Pharmaceutical-Medical device (Pharma-Dev Zones) Ecozones to Accelerate Medical Manufacturing

Featured Activity || FDA, PRC, and PRBOP Inked Memorandum of Agreement

The Ceremonial Signing of the Memorandum of Agreement (MOA) among the Food and Drug Administration (FDA), the Professional Regulation Commission...
Read More
Featured Activity || FDA, PRC, and PRBOP Inked Memorandum of Agreement

Featured Activity || DG Zacate Visits FDA RFO II in Tuguegarao City, Cagayan

Food and Drug Administration (FDA) Director General Dr. Samuel A. Zacate embarked on an ocular inspection at the FDA Regional...
Read More
Featured Activity || DG Zacate Visits FDA RFO II in Tuguegarao City, Cagayan

Our Services

For Products and Establishments registration at FDA

Verification Portal

Check the List of Approved FDA
Authorizations

eServices Portal

New Online Application System for FDA Authorizations

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

RRDportal

Applications for Licensing and Registration of Radiation Facilities and Other Related Authorizations

Verification Portal

Verification Portal

Check the List of Approved FDA
Authorizations

eServices

eServices Portal

New Online Application System for FDA Authorizations

ePortal

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

v2 ePorta1

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

RRDportal_icon

RRDportal

Applications for Licensing and Registration of Radiation Facilities and Other Related Authorizations

COVID19-related Updates

(Click Logo below for Updates)

Latest Advisories

FDA Advisory No.2024-0643 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “SUSAN’S Pure Peanut Butter”

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More

FDA Advisory No.2024-0650 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “SPROUT Berberine Dietary Supplement “

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More

FDA Advisory No.2024-0648 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “SWANSON Green Tea Antioxidant Support Herbal Supplement”

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More

FDA Advisory No.2024-0646 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “YOUWEMED Berberine (Berberine and Cinnamon) Dietary Supplement”

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More

FDA Advisory No.2024-0645 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “BODYXPERT Magnesium Glycinate Fully Chelated Dietary Supplement”

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More

FDA Advisory No.2024-0637-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong...
Read More

Announcement

FDA approved 3 additional kits today, 27 March 2020. Total registered COVID-19 Test Kits for commercial use is now 18.
UPDATE as of 4PM: FDA approved 3 additional kits today, 27 March 2020. Total registered COVID-19 Test Kits for commercial ...
Read More
FDA approved 3 additional kits today, 26 March 2020. Total registered COVID-19 Test Kits for commercial use is now 15.
UPDATE as of 2PM: FDA approved 3 additional kits today, 26 March 2020. Total registered COVID-19 Test Kits for commercial ...
Read More
FDA approved 2 additional kits today, 25 March 2020. Total registered COVID-19 Test Kits for commercial use is now 12.
UPDATE as of 4PM: FDA approved 2 additional kits today, 25 March 2020. Total registered COVID-19 Test Kits for commercial ...
Read More

FDA on the News

FDA on the News || QC gov’t at FDA sanib pwersa para palakasin ang MSMEs

Nakipagsanib puwersa ang lokal na pamahalaan ng Quezon City sa Food and Drug Administration para palakasin pa ang Micro, Small,...
Read More

FDA on the News || LGU, FDA kapit-bisig sa pagpapalago sa MSMEs sa QC

MANILA, Philippines – NAIS palawakin pa ng Quezon City Local Governmemt ang suporta para sa mga Micro Small and Medium...
Read More

FDA on the News || QC, FDA ink assistance agreement for MSMEs

The Quezon City government and the Food and Drug Administration (FDA) signed on Friday, April 14, a memorandum of agreement...
Read More

FDA on the News || QC gov’t partners with FDA to aid MSMEs

MANILA, Philippines — The Quezon City government has joined forces with the Food and Drugs Administration (FDA) to support micro,...
Read More

FDA on the News || QC, FDA ink agreement to aid MSMEs

MANILA – The Quezon City local government and the Food and Drug Administration (FDA) have agreed to work together to help...
Read More

FDA on the News || QC, FDA partner on micro business development

In a bid to help micro, small and medium enterprises (MSMEs), the Quezon City government on Friday partnered with the...
Read More

FDA on the News || Quezon City LGU at FDA, kapit-bisig sa pagpapalago ng MSMEs

MANILA, Philippines — Palalawakin pa ng Quezon City Local Government ang suporta para sa mga Micro Small and Medium Enterprises...
Read More

FDA on the News || Quezon City, FDA to help MSMEs create more jobs (MANILA TIMES)

QUEZON City Mayor Maria Josefina "Joy" Belmonte on Friday announced that the local government has joined forces with the Food...
Read More

FDA on the News || The Quezon City government yesterday partnered with the Food and Drug Administration (FDA) to provide technical assistance and training for micro, small and medium enterprises (MSMEs) in the city.

The partnership is part of the city’s Bigyang-Halaga, Bangon MSMEs (BBMSME) program, which aims to streamline registration processes and make...
Read More

FDA on the News || SMNI News: Quezon City at FDA, lumagda ng kasunduan upang tulungan ang MSMEs

Mabibigyan ng pagkakataon ang mga Micro, Small, and Medium Enterprises ng Lungsod ng Quezon na mapadali at maintindihan ang pagkakaroon...
Read More

Press Statements

FDA Press Statement || FDA and PNP-CIDG Joint Operations in North Luzon

In a collaborative effort to safeguard public health and safety, the Food and Drug Administration (FDA) North Luzon Cluster, under...
Read More

FDA Press Statement || Karapatan ng mga Senior Citizens sa 20% Discount, Binigyan-diin ng FDA

Bilang suporta sa direktiba ni Pangulong Ferdinand “Bongbong” R. Marcos Jr. na bigyang-diin ang pagsunod sa Republic Act 9994 o...
Read More

FDA Press Statement || Pag-apruba ng Generic Drug mas Pinaikli, Mula 120 Working Days, 45 Days na lang

Alinsunod sa direktiba ng Pangulong Ferdinand R. Marcos Jr. na magbigay tugon at gawing mabisa at mapabilis ang serbisyo ng...
Read More

Press Release || THE FOOD AND DRUG ADMINISTRATION (FDA) LAUNCHES TASKFORCE ALECTRYON TO FOCUS ON THE EVALUATION OF AVIAN FLU VACCINE

“THE FOOD AND DRUG ADMINISTRATION (FDA) LAUNCHES TASKFORCE ALECTRYON TO FOCUS ON THE EVALUATION OF AVIAN FLU VACCINE” In its...
Read More

FDA Press Statement || Food and Drug Administration’s (FDA) Commitment to Public Health Protection and Establishment of Technical Working Group (TWG) “Oplan Katharos”

The Food and Drug Administration (FDA) is unwavering in its dedication to safeguarding public health against the proliferation of counterfeit, adulterated,...
Read More

FDA Press Statement || Food and Drug Administration’s (FDA) Commitment to Public Health Protection and Establishment of Technical Working Group (TWG) “Oplan Katharos”

The Food and Drug Administration (FDA) is unwavering in its dedication to safeguarding public health against the proliferation of counterfeit,...
Read More

FDA Press Statement || FDA joins #MedSafetyWeek 2023

Play your part in medicines safety. Whether you’re a patient, doctor, nurse, or pharmacist, you can help make medicines safer...
Read More

FDA Press Statement || Press Release on the F-Pop Initiative

The Food and Drug Administration (FDA) is pleased to announce the launch of the Functional Pop Beauty “F-Pop” Initiative, a...
Read More

FDA Press Statement || FDA – DTI Price Monitoring at Inspection sa Divisoria 18 August 2023

Nakiisa ang Food and Drug Administration (FDA) sa isinagawang price monitoring and inspection ng Department of Trade and Industry (DTI)...
Read More
Transparency-Seal

FOI

ISO

Citizens-Charter

GAD

Verification-Logo

Pharmacovigilance

Pharmacovigilance

Draft for Comments

Draft for Comments || Standard for Vinegar and Code of Practice for its Manufacture Repealing Administrative Order No. 134 s. 1970 “Regulation Prescribing the Standards of Identity and Quality of Vinegar (B-4.9 Condiments, Sauces, Seasoning)”

All concerned stakeholders may submit comments in MSWord format via email to [email protected] on or before 26 April 2024 using...
Read More
Draft for Comments || Standard for Vinegar and Code of Practice for its Manufacture Repealing Administrative Order No. 134 s. 1970 “Regulation Prescribing the Standards of Identity and Quality of Vinegar (B-4.9 Condiments, Sauces, Seasoning)”

Draft for Comments || Guidelines on the Classification of Deficiencies Observed During Inspection of Drug Distributors, Drugstores, Hospital Pharmacies and Retail Outlet for Non-Prescription Drugs (RONPD)

All concerned stakeholders may submit comments  via email to [email protected]. The deadline for submission of comment is on 08 May...
Read More
Draft for Comments || Guidelines on the Classification of Deficiencies Observed During Inspection of Drug Distributors, Drugstores, Hospital Pharmacies and Retail Outlet for Non-Prescription Drugs (RONPD)

Draft for Comments || Guidelines on Medical Preparedness and Response to a Nuclear or Radiological Emergency and Medical Management of Radiation Injuries

In line with the Food and Drug Administration's internal rules on the development of administrative issuances, the Center for Device...
Read More
Draft for Comments || Guidelines on Medical Preparedness and Response to a Nuclear or Radiological Emergency and Medical Management of Radiation Injuries

Draft for Comments || Prescribing the Guidelines on Good Manufacturing Practice (GMP) for Drug Manufacturers Repealing AO No. 2013-0022

The Food and Drug Administration through the Policy and Planning Service is hereby posting the attached proposed Administrative Order titled,...
Read More
Draft for Comments || Prescribing the Guidelines on Good Manufacturing Practice (GMP) for Drug Manufacturers Repealing AO No. 2013-0022

Draft for Comments || Prescribing the Rules and Regulations on the Registration of Pharmaceutical Products, including Drug Substances, Intended Solely for Export

All comments are requested to be submitted in MS Word Format via e-mail to [email protected]. The deadline for submission of...
Read More
Draft for Comments || Prescribing the Rules and Regulations on the Registration of Pharmaceutical Products, including Drug Substances, Intended Solely for Export

Draft for Comments || Supplemental Guidelines on the Management and Conduct of Product Recall for Prepackaged Processed Food Products

Kindly submit your comments in MSWord format on or before 15 March 2024 via email to [email protected] using the format attached.  ...
Read More
Draft for Comments || Supplemental Guidelines on the Management and Conduct of Product Recall for Prepackaged Processed Food Products

Draft for Comments || Prescribing the Rules, Requirements and Procedures in the Application for License to Operate of Covered Health Product Establishments with the Food and Drug Administration Repealing for the Purpose Administrative Order No. 2020-0017

The Food and Drug Administration through the Policy and Planning Service is hereby posting the attached proposed Administrative Order entitled,...
Read More
Draft for Comments || Prescribing the Rules, Requirements and Procedures in the Application for License to Operate of Covered Health Product Establishments with the Food and Drug Administration Repealing for the Purpose Administrative Order No. 2020-0017

Draft for Comments || Extension of the Regulatory Flexibility for Class B, C and D Medical Devices that are Not Included in the List of Registrable Medical Devices Based on FDA Circular No. 2020-001-A entitled “Amendment to Annex A of FDA Circular No. 2020-001 re: Initial Implementation of Administrative Order No. 2018-0002 “Guidelines Governing the Issuance of an Authorization for a Medical Device based on the ASEAN Harmonized Technical Requirements””

All comments may be sent to [email protected]. The deadline for submission of comments is on 22 February 2024. I. RATIONALE...
Read More
Draft for Comments || Extension of the Regulatory Flexibility for Class B, C and D Medical Devices that are Not Included in the List of Registrable Medical Devices Based on FDA Circular No.  2020-001-A entitled “Amendment to Annex A of FDA Circular No. 2020-001 re: Initial Implementation of Administrative Order No. 2018-0002 “Guidelines Governing the Issuance of an Authorization for a Medical Device based on the ASEAN Harmonized Technical Requirements””

Draft for Comments || Guidelines for the Classification of Vitamins and Minerals for Food/Dietary Supplements under Processed Food Product Repealing the Provisions for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food”

Please be informed that the CFRR has drafted the attached FDA Circular entitled “Guidelines for the Classification of Vitamins and...
Read More
Draft for Comments || Guidelines for the Classification of Vitamins and Minerals for Food/Dietary Supplements under Processed Food Product Repealing the Provisions for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food”

Draft for Comments || Guidelines on the Recall of Health Products Regulated by the Food and Drug Administration

All concerned stakeholders may submit comments in MS word format via email to [email protected]. The deadline for submission of comment...
Read More
Draft for Comments || Guidelines on the Recall of Health Products Regulated by the Food and Drug Administration

Bids and Awards

NP-SVP(A)-2024-0084-PPS RFQ || Rental of Bus for HPDPB Workshop (Health Policy Cycle and Capacity Building on Research Management) on 28-30 May 2024

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Rental of Bus for HPDPB Workshop (Health Policy Cycle and Capacity Building on Research...
Read More
NP-SVP(A)-2024-0084-PPS RFQ || Rental of Bus for HPDPB Workshop (Health Policy Cycle and Capacity Building on Research Management) on 28-30 May 2024

ITB No. 2024-0053-CSL || Supply, Delivery, Installation, Commissioning, and Testing of Brand New Storage and Microbiological Equipment complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Alabang and Cebu Testing and Quality Assurance Laboratories (ATQAL and CTQAL)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply, Delivery, Installation, Commissioning, and Testing of Brand New Storage and Microbiological Equipment complete...
Read More
ITB No. 2024-0053-CSL || Supply, Delivery, Installation, Commissioning, and Testing of Brand New Storage and Microbiological Equipment complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Alabang and Cebu Testing and Quality Assurance Laboratories (ATQAL and CTQAL)

ITB No. 2024-0052-CSL || Supply, Delivery, Installation, Commissioning, and Testing of Brand-New Equipment Enclosures complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Alabang, Cebu, and Davao Testing and Quality Assurance Laboratories (ATQAL, CTQAL, and DTQAL)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply, Delivery, Installation, Commissioning, and Testing of Brand-New Equipment Enclosures complete with all necessary...
Read More
ITB No. 2024-0052-CSL || Supply, Delivery, Installation, Commissioning, and Testing of Brand-New Equipment Enclosures complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Alabang, Cebu, and Davao Testing and Quality Assurance Laboratories (ATQAL, CTQAL, and DTQAL)

NP-LRP-V-2024-0038-RFO-IX-REN || Notice of Renewal

Read More
NP-LRP-V-2024-0038-RFO-IX-REN || Notice of Renewal

NP-SVP(A)-2024-0067-PPS || Procurement for the Supply and Delivery of Various Collaterals for CY 2024 Activities of the Policy Planning Service- Policy Dissemination and Training Division (PPS-PDTD)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Various Collaterals for CY 2024 Activities of...
Read More
NP-SVP(A)-2024-0067-PPS || Procurement for the Supply and Delivery of Various Collaterals for CY 2024 Activities of the Policy Planning Service- Policy Dissemination and Training Division (PPS-PDTD)

ITB No. 2024-0049-AFS || Procurement of Security Services for the Food and Drug Administration (FDA) – Central Office, Alabang, Muntinlupa City (Including FDA Warehouse and CSL-SSDL located at DOH-Fabella Hospital) for a period of One (1) Year

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Security Services for the Food and Drug Administration (FDA) - Central Office,...
Read More
ITB No. 2024-0049-AFS || Procurement of Security Services for the Food and Drug Administration (FDA) – Central Office, Alabang, Muntinlupa City (Including FDA Warehouse and CSL-SSDL located at DOH-Fabella Hospital) for a period of One (1) Year

ITB No. 2024-0037-FDA || Procurement for Janitorial Services for Food and Drug Administration

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for Janitorial Services for Food and Drug Administration Bidding Documents Supplemental Bid Bulletin...
Read More
ITB No. 2024-0037-FDA || Procurement for Janitorial Services for Food and Drug Administration

NP-RFP-2024-0064-IMS || Request for Proposal: Procurement for the Engagement of Services of a Certification Body to Conduct 2nd Surveillance Audit of the ISO 9001:2015 Standard Requirements

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Request for Proposal: Procurement for the Engagement of Services of a Certification Body to...
Read More
NP-RFP-2024-0064-IMS || Request for Proposal: Procurement for the Engagement of Services of a Certification Body to Conduct 2nd Surveillance Audit of the ISO 9001:2015 Standard Requirements

ITB No. 2024-0051-CSL || Supply, Delivery, Installation, Commissioning and Testing of Brand-New Pharmaceutical Equipment complete with all necessary parts and accessories for the Common Services Laboratory (CSL) – Alabang and Cebu Testing and Quality Assurance Laboratories (ATQAL and CTQAL)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply, Delivery, Installation, Commissioning and Testing of Brand-New Pharmaceutical Equipment complete with all necessary...
Read More
ITB No. 2024-0051-CSL || Supply, Delivery, Installation, Commissioning and Testing of Brand-New Pharmaceutical Equipment complete with all necessary parts and accessories for the Common Services Laboratory (CSL) – Alabang and Cebu Testing and Quality Assurance Laboratories (ATQAL and CTQAL)

ITB No. 2024-0050-CSL || Supply, Delivery, Installation, Commissioning and Testing of Brand-New Balances and Set of Weights complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Alabang, Cebu and Davao Testing and Quality Assurance Laboratories (ATQAL, CTQAL and DTQAL)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply, Delivery, Installation, Commissioning and Testing of Brand-New Balances and Set of Weights complete...
Read More
ITB No. 2024-0050-CSL || Supply, Delivery, Installation, Commissioning and Testing of Brand-New Balances and Set of Weights complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Alabang, Cebu and Davao Testing and Quality Assurance Laboratories (ATQAL, CTQAL and DTQAL)

Latest Issuances

FDA Circular No.2024-001 || Recall and Withdrawal of the Classification and Registration of Domperidone as Over-the-Counter Drug

I. BACKGROUND It is the policy of the State to promote and protect the right to health of the people...
Read More

FDA Circular No.2023-012 || Recognition of Accredited Technical Service Providers for Radiation Dosimetry of Individual Monitoring Services

I. BACKGROUND The Food and Drug Administration, though the Center for Device Regulation, Radiation Health, and Research (FDA -CDRRHR) is...
Read More

FDA Circular No.2023-011 || Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted During the 37th ASEAN Cosmetic Committee (ACC) Meeting and its Related Meetings

I. BACKGROUND In 2005, the Department of Health (DOH) – Food and Drug Administration (FDA), then Bureau of Food and...
Read More

FDA CIRCULAR No.2023-010 || Guidelines on the Conduct of the Food and Drug Administration Trainings and Seminars Offered by the FDA Academy to the External Stakeholders

I. RATIONALE The Food and Drug Administration (FDA) through the FDA Academy conducts training programs for its stakeholders on health...
Read More
Shares